Overview of Gripex Noc

Quick Facts

Property	Description
Active Ingredients	Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride
Form	Coated tablets (Oral administration)
Pharmacological Class	Upper Respiratory Combinations
General Purpose	Symptomatic relief of cold and flu symptoms
Origin	Synthetically derived compounds

Gripex Noc: Definition and Pharmacological Classification

Gripex Noc is an Over-The-Counter (OTC), multi-component medicinal product available in the form of coated tablets for oral administration, used for the symptomatic relief of common cold and flu-like symptoms. It is classified within the pharmacological group known as Upper Respiratory Combinations, signifying that it is designed to address multiple co-occurring upper respiratory symptoms. This medicine is a blend of four distinct, synthetically derived active substances, setting it apart from single-agent relief options. Its specific combination is widely used in central and eastern European markets, reflecting a common regulatory approach to treating complex cold symptoms.

Composition of Gripex Noc: A Four-Component Formula

Gripex Noc is characterized by its specific four-component formula, containing the active ingredients Acetaminophen (analgesic/antipyretic), Chlorpheniramine Maleate (antihistamine), Dextromethorphan Hydrobromide (antitussive), and Pseudoephedrine Hydrochloride (decongestant). The formula benefits from a pharmacologically supported strategy of symptom management, as combination products containing Acetaminophen and a decongestant provide relief from nasal obstruction and headache associated with the common cold. Furthermore, Dextromethorphan is clinically recognized as an effective cough suppressant. By merging these four therapeutic agents, the medicine is designed to simultaneously manage the multiple symptoms—pain, fever, cough, and congestion—that often define an acute cold or influenza infection.

Why is Gripex Noc a Nighttime (Noc) Formulation?

The "Noc" (Nighttime) designation signifies that the formulation is specifically tailored for use before sleep, providing relief that supports rest, typically targeting adults and adolescents. This nighttime suitability primarily results from the inclusion of Chlorpheniramine Maleate, a first-generation antihistamine known for its established sedative property. The general therapeutic purpose of this specific combination is to mitigate the most disruptive symptoms—like persistent coughing and nasal blockage—which typically interfere with the ability to fall asleep and remain asleep during an illness, offering a comprehensive relief profile focused on rest.

Regulatory References

National Library of Medicine

What side effects are possible with Gripex Noc?

Possible Side Effects and Safety Information

The safety profile for this multi-component medicine is structured according to official regulatory classification systems, defining the nature and frequency of possible adverse reactions. These effects are formally categorized by the physiological systems they affect and their documented likelihood of occurrence.

Officially Documented Adverse Reactions

The most frequently classified reactions, defined as Very Common or Common in regulatory documents, relate primarily to the Central Nervous System and Autonomic Nervous System. These typically include somnolence (drowsiness), sedation, dizziness, headache, and dry mouth. Some of these effects may be more pronounced at the start of treatment and may subside over time.

Serious Adverse Reactions and Constraints

While uncommon, the official labeling highlights the potential for serious adverse reactions. The most critical risk is severe hepatotoxicity (liver damage) associated with the Acetaminophen component, which underscores the mandatory restriction on the maximum cumulative daily dose of Acetaminophen from all sources. Other documented serious adverse reactions include severe allergic events like Anaphylaxis and rare hematological disorders such as Agranulocytosis. Use is formally contraindicated in individuals taking a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.

Population-Specific Safety Notes

Regulatory documents outline specific safety considerations for certain patient groups. Older adults may have an increased risk of experiencing central nervous system effects, such as confusion or somnolence, as well as urinary retention. Caution is also required for patients with pre-existing hepatic impairment due to the risk of increased liver damage.

Overdose and Emergency Response

The official regulatory profile for Gripex Noc overdose is governed by the risk of severe liver damage associated with the Acetaminophen component, which can lead to death if not immediately managed. Documented initial clinical manifestations of toxicity include non-specific symptoms such as nausea, vomiting, loss of appetite, sweating, and weakness. Later signs indicating progressive hepatotoxicity may involve stomach pain (upper right side), dark urine, and the development of yellowing of the skin or eyes (jaundice). Toxicity from the other active ingredients may result in severe drowsiness or excitability.

Regulatory documents mandate that users must seek medical help or contact a Poison Control Center right away following a suspected overdose. This action is critical for adults as well as for children, and its urgency applies even if you do not notice any signs or symptoms. The severe-outcome risk is increased when excessive daily doses are taken, when consuming other Acetaminophen-containing products, or with concurrent, chronic use of alcohol. Hospital management focuses on symptomatic and supportive treatment, including the use of the specific antidote, N-acetylcysteine, for Acetaminophen toxicity.

Therapeutic Uses of Gripex Noc

What Gripex Noc Treats: Main Uses and Benefits

Gripex Noc is commonly used to help with symptomatic relief for acute, disruptive manifestations of the common cold and influenza (flu-like conditions). The medication is applied in situations where symptoms cluster into patterns requiring supportive management, focusing on key domains of discomfort.

The formulation is relevant in contexts where symptoms create noticeable interference, helping to ease a disruptive combination of fever, headache, minor aches and pains, nasal congestion, runny nose, sneezing, and dry cough. It is relevant when symptoms become more noticeable during the nighttime.

“The medication supports a sense of stability when acute systemic and respiratory symptoms are pronounced, contributing to improved comfort during periods of heightened symptoms.”

Quick Fact: Relief for Nighttime Symptoms

Category	Symptom Management
Systemic Symptoms	Relief from fever, body aches, and headache.
Respiratory Symptoms	Management of nasal congestion, runny nose, sneezing, and dry cough.
Usage Context	Relevant for supporting rest during acute nighttime discomfort.
Patient Benefit	Helps patients cope more steadily with symptom fluctuations and supports improved rest.

Regulatory References

Health Canada Non-prescription Cold and Flu Labelling Standard

Eligibility and Restrictions for Use

Who Can and Cannot Use Gripex Noc?

This section outlines the official, regulator-mandated population eligibility criteria for Gripex Noc.

Eligibility Scope

Category	Official Regulatory Status
Populations for whom use is allowed:	Adults and adolescents 12 years of age and older.
Populations for whom use is contraindicated:	Children under 12 years; pregnant women; women who are breastfeeding; patients with known hypersensitivity to any component.
Condition-specific eligibility rules (Contraindications):	Severe liver failure, severe acute/chronic kidney disease, severe/uncontrolled arterial hypertension, unstable coronary artery disease, viral hepatitis, alcohol dependence, G6PD deficiency, and concurrent use with MAOIs (or within 14 days).

Official Eligibility Statements

Use is permitted only for individuals who are 12 years of age and older.
Use is strictly prohibited for children under 12 and for women who are pregnant or breastfeeding.
Absolute contraindications include severe organ failure, such as severe liver and renal failure.
Caution is required for patients with pre-existing conditions like diabetes mellitus, glaucoma, epilepsy, non-severe hypertension, and chronic lung diseases.

These rules define the official boundaries for use, ensuring the medication is reserved for the approved age group and withheld from specific high-risk populations as documented in regulatory guidelines.

What should I know about interactions with other medicines?

Gripex Noc has a documented interaction profile due to its four active components, and co-administration with certain substances is formally contraindicated by regulatory authorities. This includes Monoamine Oxidase Inhibitors (MAOIs), where a mandatory 14-day separation window is required after stopping the MAOI before taking this medicine. Use is also strictly prohibited with other medicinal products containing Acetaminophen to prevent the risk of acute hepatic damage from exceeding maximum daily dose thresholds.

The medicine is subject to several clinically significant pharmacodynamic interactions. Due to the Chlorpheniramine content, co-administration with Central Nervous System (CNS) Depressants, such as alcohol, sedatives, or opioids, may lead to additive CNS depression and increased drowsiness. Furthermore, combining with Serotonergic Drugs (including SSRIs or Tricyclic Antidepressants) carries an officially documented risk of Serotonin Syndrome due to the Dextromethorphan component.

Pharmacokinetic interactions are also specified in regulatory labeling. Strong CYP2D6 Inhibitors (e.g., Fluoxetine or Paroxetine) may significantly increase the plasma concentration (exposure) of Dextromethorphan. Chlorpheniramine may also cause inhibition of phenytoin metabolism, potentially leading to phenytoin toxicity. An increased risk of liver damage is formally associated with the consumption of three or more alcoholic drinks daily due to the Acetaminophen component. Specific caution for the interaction profile is noted for patients with Severe Liver Disease due to accumulation risks.

Mechanism of Action

How Gripex Noc Works

The mechanism of action is based on three distinct pharmacodynamic domains targeting central and peripheral pathways. The Paracetamol component primarily acts within the central nervous system (CNS), inhibiting specific cyclooxygenase (COX) enzyme activity. This action limits prostaglandin synthesis, altering signaling input to the nociceptive and thermoregulatory centers, thereby influencing the pain perception threshold and hypothalamic temperature set point.

The Pseudoephedrine component engages the peripheral sympathetic nervous system. It acts as an alpha-adrenergic receptor agonist on vascular smooth muscle cells in the respiratory tract. This interaction initiates a signaling cascade that induces vasoconstriction, a physiological adjustment that decreases tissue fluid accumulation and engorgement of the nasal mucosa.

Finally, the Dextromethorphan component targets signaling pathways in the brain's medulla oblongata. By modulating neurotransmitter activity and engaging excitatory receptors, it intervenes in the neural arc that processes the cough signal. This action elevates the afferent signal magnitude required to trigger the reflex arc, resulting in the suppression of signal efference from the central cough center.

Dosage and Administration Information

How to Use Gripex Noc: Official Administration Guidelines

Administration of Gripex Noc is governed by documents that outline the specific route, dosage, frequency, and duration of use for the four-component formulation (Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, and Pseudoephedrine Hydrochloride).

Administration Scope

The medicine is intended for oral administration as a fixed-dose unit.

Feature	Official Specification
Dosing Schedule	Adults and adolescents 12 years of age and older take 2 coated tablets per dose.
Maximum Dose	The total daily intake must not exceed 8 tablets in any 24-hour period.
Frequency	Doses should be separated by a minimum interval of 6 hours and administered as needed while symptoms persist.
Age Rules	Use is approved for individuals 12 years of age and older. Use in younger children requires specific medical direction.

Procedural Administration Constraints

The method of administration is subject to certain procedural constraints:

Tablets must be swallowed whole with water; they are not intended to be crushed, chewed, or dissolved, as this may alter their intended release profile.
The product is designated for use specifically during sleeping hours to align with its nighttime (Noc) formulation.
If a dose is missed, instructions advise the patient to skip the missed dose and resume the regular schedule; double doses must not be taken.
The administration is strictly for short-term use, and the course of treatment should generally not exceed 10 consecutive days.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Gripex Noc

Evidence for Multi-Symptom Relief in Cold and Flu

The clinical evaluation of multi-component cold and flu medicines was evaluated in Randomized Controlled Trials (RCTs). These short-term studies are used in research exploring how symptoms change over time and typically include otherwise healthy adults and adolescents experiencing cold or flu-like symptoms. Researchers examined outcomes related to physical discomfort by measuring a composite Total Symptom Score (TSS). Available research exploring short-term symptom changes, such as single-dose RCTs on the exact four-component combination, has reported measurements of change in the Total Symptom Score that contained inconsistent findings in comparison to placebo in specific trials. This evidence provides insight into short-term changes and contributes to the broader evidence landscape.

Evidence Specific to Nighttime Symptom Management

The design for nighttime use is relevant in trials assessing short-term or episodic symptom patterns that disrupt rest. Research has explored the inclusion of the sedating antihistamine component (Chlorpheniramine Maleate), leveraging its established property. Studies monitored outcomes capturing phases of heightened symptom activity, such as persistent cough and congestion. The evidence supporting the nighttime designation is relevant to the established sedative property of the first-generation antihistamine component. However, existing evidence for the full four-component product provides insight based on general cold symptom relief, rather than studies that used validated tools to measure objective sleep quality or duration.

What Research Gaps and Uncertainties Remain

The research highlights what is known—and what is still uncertain—about this formulation. A key limitation is that some single-dose trials designed to test symptom changes showed mixed findings, indicating that research exploring short-term symptom changes for the four-component combination requires further study. Long-term effects are not fully established, as follow-up durations were limited to short-course treatment periods. Data for certain outcomes remain insufficient, and comparative evidence is lacking to definitively understand how this specific four-ingredient product performs against all other single-ingredient remedies.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Gripex Noc (FAQ)

Q: Is it common to feel drowsy the morning after taking Gripex Noc?

A: Official labeling describes the ingredient Chlorpheniramine Maleate as having a half-life that may contribute to residual effects. Drowsiness (somnolence) is listed as a common adverse reaction associated with this medication. Therefore, it is possible for some users to experience lingering effects upon waking the next morning.

Q: What is the duration of action expected for Gripex Noc?

A: Regulatory documents specify that doses of this medicine should be separated by a minimum of 6 hours. This mandatory interval is established based on the minimum duration of therapeutic effect expected from the combination of active components in the formula.

Q: How quickly can I expect to feel the effects of Gripex Noc?

A: Pharmacokinetic data available in official documents provide insight into the medicine's action. The individual active components generally reach their maximum concentration in the bloodstream within 1 to 3 hours after the product is taken orally, which provides an indication of the time to expected effect.

Q: What kind of studies or research support the claims made for Gripex Noc?

A: The medicinal claims are supported by an evidence base including data from Randomized Controlled Trials (RCTs). These studies have examined the combination of components by measuring changes in symptom scores related to the common cold and flu.

Q: Are there any ingredients in Gripex Noc that might be related to addiction?

A: Official warnings address the potential for the cough-suppressant ingredient, Dextromethorphan, to be associated with physical and psychological dependence upon prolonged use, and note the potential for misuse. The product is designated for short-term, symptomatic relief only.

Q: Is it possible to take Gripex Noc and still have trouble sleeping?

A: While the formulation includes an ingredient with an established sedative property, the primary research supporting the product did not use validated tools to measure objective sleep quality or duration. Therefore, the response to the medicine's effect on sleep may vary among individuals.

Q: Does Gripex Noc affect the results of any common medical tests?

A: Regulatory information indicates that certain components, such as Acetaminophen, may interfere with the results of specific laboratory measurements. These include tests for substances like urine 5-hydroxyindoleacetic acid and certain methods used to measure blood glucose.

Q: Can people who have asthma take Gripex Noc?

A: Official regulatory documents state that caution is formally required for patients with pre-existing chronic lung diseases, which may include asthma. This is due to the potential for certain components of the medicine to affect respiratory function.

Q: Is Gripex Noc considered safe to take with common vitamins or supplements?

A: The official interaction profile details specific drug-to-drug interactions. Regulatory documents list interactions with specific drug types, such as CYP2D6 inhibitors. Caution is advised regarding known interactions in this category, including those posed by certain supplements or herbal products.

Q: What are the general guidelines for using Gripex Noc during breastfeeding?

A: Regulatory documents strictly prohibit the use of this medicine during breastfeeding. This restriction is based on the official determination that the active substances are known to be excreted into human breast milk, which may pose a risk to the nursing infant.

Q: Does Gripex Noc affect blood sugar levels?

A: Caution is formally required for patients with diabetes mellitus. The Pseudoephedrine component (a decongestant) can potentially affect blood glucose control or interact with diabetes medications, as noted in official warnings.

Q: Can I take Gripex Noc if I am on medication for anxiety or depression?

A: Official labeling highlights the risk of Serotonin Syndrome when combined with certain medications like SSRIs or Tricyclic Antidepressants. Additionally, combining this medicine with other Central Nervous System (CNS) depressants used for anxiety may cause additive drowsiness.

Q: Are there any long-term side effects that have been studied for Gripex Noc?

A: Official administration guidelines state that the course of treatment should not exceed 10 consecutive days, indicating this is intended for short-term use. Consequently, the clinical research supporting the product is also limited to short-course treatment periods.

Q: Are there any common foods or drinks that should be avoided when using Gripex Noc?

A: Regulatory documents contain a specific warning regarding the daily consumption of three or more alcoholic drinks. This level of consumption is formally associated with an increased risk of liver damage when combined with the Acetaminophen component of the medicine.

Q: Is Gripex Noc gluten-free or suitable for people with dietary restrictions?

A: While the excipients (non-active components) are listed in official documents, specific certifications such as 'gluten-free' are generally not included in the core regulatory summary. Users should check the full list of ingredients or consult the product label for dietary suitability.

Q: What is the official recommended age for using Gripex Noc?

A: The official regulatory profile specifies that use is approved for adults and adolescents 12 years of age and older. The use of this medicine is strictly prohibited for children under the age of 12.

Q: Can Gripex Noc affect mood or cause restlessness in some people?

A: Officially documented adverse reactions sometimes include effects on the nervous system such as anxiety, restlessness, or agitation. These effects are generally associated with the decongestant and antihistamine components of the formulation.

Q: Does Gripex Noc interact with herbal teas or remedies?

A: The regulatory interaction profile specifically highlights the potential for interaction with strong CYP2D6 inhibitors. Official documentation advises caution regarding products that are known to act as enzyme inhibitors, which can include some herbal remedies.

Q: Is there a risk of becoming tolerant to the effects of Gripex Noc over time?

A: The medicine is intended for short-term use only (not exceeding 10 consecutive days). For the decongestant component, official warnings may include the risk of rebound congestion or diminished effect with prolonged or repeated use.

Q: What is the rationale behind the combination of ingredients in Gripex Noc?

A: The combination is intended to provide simultaneous relief for the common cluster of cold and flu symptoms. This includes targeting pain/fever (Acetaminophen), congestion (Pseudoephedrine), cough (Dextromethorphan), and runny nose/rest-disrupting symptoms (Chlorpheniramine).

Q: Does Gripex Noc help with nasal congestion or just clear the nose?

A: The Pseudoephedrine component is classified as a decongestant. Its action is described as inducing vasoconstriction (narrowing of blood vessels) in the respiratory tract. This physiological change decreases fluid accumulation in the nasal tissues, leading to the relief of nasal congestion.

Q: Why do some people experience mild headaches after taking Gripex Noc?

A: Regulatory documents formally list headache as a common adverse reaction associated with the use of this medicine. This is a known systemic effect that has been documented in clinical studies.

Q: What evidence exists regarding the effectiveness of Gripex Noc for multiple symptoms?

A: Research has explored the effectiveness of this multi-component approach by examining outcomes related to physical discomfort using a composite Total Symptom Score (TSS). Available evidence from studies on combination products supports the relief of multiple symptoms, such as nasal obstruction and headache.

How should Gripex Noc be stored and disposed of?

The official regulatory profile for Gripex Noc defines specific mandatory conditions for storage, stability, and disposal.

Storage Conditions

Gripex Noc must be stored at a temperature not exceeding 25 C. The product is required to be kept in its original container (blister and carton) and must not be used after the expiry date printed on the packaging.

Child Safety and Disposal

A critical requirement is that the medicine must be stored in a location that is out of the sight and reach of children.

For disposal, the regulatory mandate is to not dispose of the medicine via household waste or wastewater. Instead, users are instructed to consult a pharmacist on how to discard unused or expired tablets to ensure environmental protection.

Gripex Noc